Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic.

Slides:



Advertisements
Similar presentations
Speciation by symbiosis Robert M. Brucker, Seth R. Bordenstein Trends in Ecology & Evolution Volume 27, Issue 8, Pages (August 2012) DOI: /j.tree
Advertisements

The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real? Ryan M. Thomas, Christian Jobin Trends in Cancer Volume 1, Issue 1, Pages (September 2015)
Masson's tumour: Differential diagnosis of neck lump in children Pablo Martinez Devesa, Salil Sood, Meena Chaudhari, Deepak Gupta, Suchir Maitra International.
Detection of Abdominal Aortic Aneurysm in Patients with Peripheral Artery Disease A. Barba, L. Estallo, L. Rodríguez, M. Baquer, M. Vega de Céniga European.
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Perimenopausal migraine in women with vasomotor symptoms E. Anne MacGregor Maturitas Volume 71, Issue 1, Pages (January 2012) DOI: /j.maturitas
Plantar Flexion as an Alternative to Treadmill Exercise for Evaluating Patients with Intermittent Claudication K. Yamamoto, T. Miyata, A. Onozuka, H. Koyama,
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Prognostic Significance of Declining Ankle-brachial Index Values in Patients with Suspected or Known Peripheral Arterial Disease H.H.H. Feringa, S.E. Karagiannis,
Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one.
European Journal of Cancer
Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis.
European Journal of Cancer
Volume 63, Issue 1, Pages (July 2015)
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)  Axel.
Rare cancers of the head and neck area in Europe
Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit  Pim J. van Leeuwen, David Connolly, Anna.
Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1–3 brain metastases: Results.
Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating.
Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer  Philippe O. Gannon, Laurent Lessard, Louis-Mathieu.
Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial)  M. Yoshida, K. Muro, A. Tsuji,
The PSA Era is not Over for Prostate Cancer
Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind.
The feasibility of nipple aspiration and duct lavage to evaluate the breast duct epithelium of women with increased breast cancer risk  Dominique Twelves,
Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma – Results and treatment recommendations.
Treatment of Primary Varicose Veins by Endovenous Obliteration with the VNUS Closure System: Results of a Prospective Multicentre Study  Ph. Nicolini,
Scoring to predict the possibility of upgrades to malignancy in atypical ductal hyperplasia diagnosed by an 11-gauge vacuum-assisted biopsy device: An.
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
European Journal of Cancer
Volume 58, Issue 4, Pages (October 2010)
Volume 125, Issue 4, Pages (October 2003)
P. Sooriakumaran, R. Kaba  International Journal of Surgery 
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria  M. Tazdait,
Control of Prostate Cancer by Transrectal HIFU in 227 Patients
Day case laparoscopic cholecystectomy: Reducing the admission rate
Diagnosis of irritable bowel syndrome
Cervical spine evaluation in the bluntly injured patient
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Hepatic resection of non-colorectal and non-neuroendocrine liver metastases – Survival benefit for patients with non-gastrointestinal primary cancers.
The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 53, Issue 6, Pages (June 2008)
Phase I Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG.
What Influences Patients’ Decisions on Artificial Hydration at the End of Life? A Q- Methodology Study  Catherine Malia, MSc, Michael I. Bennett, MB, ChB,
Gopi Anne McLeod, Michael Murphy, Te Marana Henare, Bernadette Dlabik 
Serum cholinesterase activity in the diagnosis of nonalcoholic fatty liver disease in type 2 diabetic patients  O.O. Ogunkeye, E.K. Chuhwak, A.A.E. Otokwula 
The Molecular Pathology of Primary Immunodeficiencies
Confessions of a journal junkie
European Urology is “Your” Journal
Recommendations for the management of patients with homozygous familial hypercholesterolaemia: Overview of a new European Atherosclerosis Society consensus.
The Role of Endoscopic Ultrasound in Solid Pancreatic Lesions: Detection, Characterization, and Assessment of Resectability  C Jenssen  Video Journal.
Volume 125, Issue 4, Pages (October 2003)
American Journal of Kidney Diseases
Charlene L. Taylor, RN, BSN  Journal of Pain and Symptom Management 
Volume 17, Issue 2, Pages (February 1950)
Statin use and clinical outcomes among pneumonia patients
Volume 63, Issue 1, Pages (July 2015)
Diagnosing pancreatic malignancy in the setting of chronic pancreatitis: is there room for improvement?  James J. Farrell, MD  Gastrointestinal Endoscopy 
Increasing incidence of brain tumours in sparsely populated areas
Evaluation of diagnostic tests
Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung  Florian Eichhorn, MD, Hendrik Dienemann, MD,
August Heidland, MD, Udo Bahner, MD, Spiros Vamvakas, MD 
Impact of antibiotic restrictions: the patient's perspective
Volume 121, Issue 3, Pages (September 2001)
Donald Gardenier, Theresa Ullrich, Erin L. Davis 
European Urology Oncology
Donald Gardenier, Theresa Ullrich, Erin L. Davis 
Is It the Difference a Day Makes
How Should End-of-Life Advance Care Planning Discussions Be Implemented According to Patients and Informal Carers? A Qualitative Review of Reviews  Alex.
Presentation transcript:

Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours?  Thomas Walter, Laurence Chardon, Xavier Chopin-laly, Véronique Raverot, Anne-Gaelle Caffin, Jean-Alain Chayvialle, Jean-Yves Scoazec, Catherine Lombard-Bohas  European Journal of Cancer  Volume 48, Issue 12, Pages 1766-1773 (August 2012) DOI: 10.1016/j.ejca.2011.11.005 Copyright © 2011 Elsevier Ltd Terms and Conditions

Fig. 1 Repartition of serum chromogranin A levels and polypeptide pancreatic (PP) levels in 115 patients with gastroenteropancreatic neuroendocrine tumours (GEPNET) according to primary tumour localisation. European Journal of Cancer 2012 48, 1766-1773DOI: (10.1016/j.ejca.2011.11.005) Copyright © 2011 Elsevier Ltd Terms and Conditions

Fig. 2 Percents of patients with initial high serum chromogranin A (CgA) levels (n=112 periods) or polypeptide pancreatic (PP) levels (n=37 periods) who showed a significant change in CgA (2A) or PP levels (2B) according to the disease evolution among Response Evaluation Criteria in Solid Tumours (RECIST) criteria. European Journal of Cancer 2012 48, 1766-1773DOI: (10.1016/j.ejca.2011.11.005) Copyright © 2011 Elsevier Ltd Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.